Charles Schwab’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-92,267
| Closed | -$280K | – | 3655 |
|
|
2023
Q2 | $280K | Sell |
92,267
-48,737
| -35% | -$148K | ﹤0.01% | 3248 |
|
|
2023
Q1 | $881K | Sell |
141,004
-8,047
| -5% | -$50.3K | ﹤0.01% | 2775 |
|
|
2022
Q4 | $909K | Buy |
149,051
+2,257
| +2% | +$13.8K | ﹤0.01% | 2801 |
|
|
2022
Q3 | $1.76M | Buy |
146,794
+3,269
| +2% | +$39.1K | ﹤0.01% | 2617 |
|
|
2022
Q2 | $1.81M | Buy |
143,525
+11,241
| +8% | +$142K | ﹤0.01% | 2598 |
|
|
2022
Q1 | $1.49M | Sell |
132,284
-2,486
| -2% | -$28K | ﹤0.01% | 2734 |
|
|
2021
Q4 | $2.39M | Buy |
134,770
+1,432
| +1% | +$25.4K | ﹤0.01% | 2640 |
|
|
2021
Q3 | $3.07M | Buy |
133,338
+43,288
| +48% | +$997K | ﹤0.01% | 2595 |
|
|
2021
Q2 | $2.1M | Buy |
90,050
+1,409
| +2% | +$32.8K | ﹤0.01% | 2700 |
|
|
2021
Q1 | $2.76M | Buy |
+88,641
| New | +$2.76M | ﹤0.01% | 2558 |
|